Richard Buchholz - Jan 11, 2023 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Financial Officer
Signature
/s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz
Stock symbol
INSP
Transactions as of
Jan 11, 2023
Transactions value $
-$3,125,359
Form type
4
Date filed
1/13/2023, 03:59 PM
Previous filing
Apr 5, 2022
Next filing
Jan 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Gift $0 -400 -0.85% $0.00 46.9K Jan 5, 2023 Direct F1
transaction INSP Common Stock Gift $0 +100 +8.89% $0.00 1.23K Jan 5, 2023 By Daughter
transaction INSP Common Stock Gift $0 +100 +8.89% $0.00 1.23K Jan 5, 2023 By Son
transaction INSP Common Stock Gift $0 +100 +8.89% $0.00 1.23K Jan 5, 2023 By Son
transaction INSP Common Stock Gift $0 +100 +8.89% $0.00 1.23K Jan 5, 2023 By Son
transaction INSP Common Stock Sale -$131K -523 -1.12% $250.00 46.4K Jan 11, 2023 Direct F2
transaction INSP Common Stock Sale -$2.99M -12K -25.83% $250.03 34.4K Jan 13, 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 80 shares acquired under the Inspire Medical Systems, Inc. (the "Company") 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2022 and (ii) 31 shares acquired under the Company Plan on December 31, 2022.
F2 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.00 to $250.25, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.